Private equity firm Warburg Pincus is nearing a deal to acquire specialty pharmacy company PANTHERx Rare for more than $7 billion, including debt, the Wall Street Journal reported, citing people familiar with the matter. Warburg is partnering with Abu Dhabi Investment Authority on the acquisition, the report said. Pittsburgh-based PANTHERx specializes in providing medicines and patient support services for rare and orphan diseases. The company is owned by an investor group that includes private equity firm General Atlantic.
Read the full article: Warburg Pincus Nears $7B Deal for PANTHERx Rare //
Source: https://www.reuters.com/legal/transactional/warburg-pincus-nears-7-billion-deal-pantherx-rare-wsj-reports-2026-07-10/